Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis
Tumor Biology · 27.04.2021 · 43 (1) · 37-55
DOI: 10.3233/tub-200058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 27.04.2021. Verfasst von Yahaya Gavamukulya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Health Sciences, Busitema University, Mbale, Uganda. Hauptthemen laut MEDLINE: Metal Nanoparticles. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: Green synthesized nanoparticles have been earmarked for use in nanomedicine including for the development of better anticancer drugs. OBJECTIVE: The aim of this study was to undertake biochemical evaluation of anticancer activities of green synthesized silver nanoparticles (AgNPs) from ethanolic extracts of fruits (AgNPs-F) and leaves (AgNPs-L) of Annona muricata. METHODS: Previously synthesized silver nanoparticles were used for the study. The effects of the AgNPs and 5-Fluorouracil were studied on PC3, HeLa and PNT1A cells. The resazurin, migration and colonogenic assays as well as qRT-PCR were employed. RESULTS: The AgNPs-F displayed significant antiproliferative effects against HeLa cells with an IC 50 of 38.58 μg/ml and PC3 cells with an IC 50 of 48.17 μg/ml but selectively spared normal PNT1A cells (selectivity index of 7.8), in comparison with first line drug 5FU and AgNPs-L whose selectivity index were 3.56 and 2.26 respectively. The migration assay revealed potential inhibition of the metastatic activity of the cells by the AgNPs-F while the colonogenic assay indicated the permanent effect of the AgNPs-F on the cancer cells yet being reversible on the normal cells in contrast with 5FU and AgNPs-L. CASP9 was significantly over expressed in all HeLa cells treated with the AgNPs-F (1.53-fold), AgNPs-L (1.52-fold) and 5FU (4.30-fold). CXCL1 was under expressed in HeLa cells treated with AgNPs-F (0.69-fold) and AgNPs-L (0.58-fold) and over expressed in cells treated with 5FU (4.95-fold), but the difference was not statistically significant. CXCR2 was significantly over expressed in HeLa cells treated with 5FU (8.66-fold) and AgNPs-F (1.12-fold) but under expressed in cells treated with AgNPs-L (0.76-fold). CONCLUSIONS: Here we show that biosynthesized AgNPs especially AgNPs-F can be used in the development of novel and better anticancer drugs. The mechanism of action of the AgNPs involves activation of the intrinsic apoptosis pathway through upregulation of CASP9 and concerted down regulation of the CXCL1/ CXCR2 gene axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Faculty of Health Sciences, Busitema University, Mbale, Uganda.
- Department of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology and Innovation, Nairobi, Kenya.
- Department of Biochemistry, College of Health Sciences, University of Nairobi, Nairobi, Kenya.
- Department of Biochemistry, Faculty of Agriculture, Cairo University, Giza, Egypt.
- Department of Biochemistry, School of Medicine and Health Sciences, Kenya Methodist University, Meru, Kenya.
- National HIV Reference Laboratory, Ministry of Health, Nairobi, Kenya.
Zitieren
APA
Gavamukulya, Y., Maina, E. N., El-Shemy, H. A., Meroka, A. M., Kangogo, G. K., Magoma, G., & Wamunyokoli, F. (2021). Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis. Tumor Biology, 43(1), 37-55. https://doi.org/10.3233/tub-200058
Vancouver
Gavamukulya Y, Maina EN, El-Shemy HA, Meroka AM, Kangogo GK, Magoma G, et al. Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis. Tumor Biology. 2021;43(1):37-55. doi:10.3233/tub-200058
BibTeX
@article{Gavamukulya2021,
author = {Gavamukulya, Yahaya and Maina, Esther N and El-Shemy, Hany A and Meroka, Amos M and Kangogo, Geoffrey K and Magoma, Gabriel and Wamunyokoli, Fred},
title = {Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis},
journal = {Tumor Biology},
year = {2021},
volume = {43},
number = {1},
pages = {37--55},
doi = {10.3233/tub-200058}
}
EUVIMED